Literature DB >> 5278102

Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia.

B Jones, J F Holland, A R Morrison, S L Lee, L F Sinks, J Cuttner, A Rausen, F Kung, H J Pluss, F I Haurani, R B Patterson, J Blom, E O Burgert, J H Moon, L Chevalier, A Sawitsky, M M Albala, R J Forcier, G Falkson, O Glidewell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5278102

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  4 in total

Review 1.  Chemotherapy of childhood lymphoblastic leukaemia: the first 50 years.

Authors:  J Lilleyman
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

2.  Daunorubicin and the heart.

Authors: 
Journal:  Br Med J       Date:  1974-11-23

3.  Treatment of acute leukemia and malignant lymphoma with (2"R)-4'-O-tetrahydropyranyladriamycin.

Authors:  R Ohno; K Kimura; I Amaki; M Hirano; A Hoshino; Y Ikeda; I Kimura; M Kobayashi; K Konno; H Majima
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 4.  Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

Authors:  V B Pai; M C Nahata
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.